Scholars have identified FSP1 inhibitor ferroptosis sensitizer 1 (FSEN1), which is a noncompetitive inhibitor that acts by selectively targeting and inhibiting FSP1 to sensitize cancer cells to ferroptosis (Elguindy and Nakamaru-Ogiso, 2015). Here, AIFM2 is linked to cancer.